Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$45.83+0.99 (+2.21%)
Close on Nov 18, 2026Market cap $3.27BP/E –Yield –
Pulse Biosciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Pulse Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$83.04M. For fiscal 2025 it was -$76.94M. The highest annual figure on record is -$4.47M in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$76.94M | – |
| FY2024 | Dec 31, 2024 | -$56.26M | – |
| FY2023 | Dec 31, 2023 | -$43.57M | – |
| FY2022 | Dec 31, 2022 | -$58.06M | – |
| FY2021 | Dec 31, 2021 | -$63.01M | – |
| FY2020 | Dec 31, 2020 | -$49.97M | – |
| FY2019 | Dec 31, 2019 | -$47.95M | – |
| FY2018 | Dec 31, 2018 | -$37.55M | – |
| FY2017 | Dec 31, 2017 | -$25.57M | – |
| FY2016 | Dec 31, 2016 | -$9.52M | – |
| FY2015 | Dec 31, 2015 | -$4.47M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$25.27M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.15M | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.25M | – |
| Q3 FY2025 | Sep 30, 2025 | -$20.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.28M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$20.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.73M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.62M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.53M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.25M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.23M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.56M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.03M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.41M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$18.53M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$12.91M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.75M | – |
| Q2 FY2019 | Jun 30, 2019 | -$11.36M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.08M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.95M | – |
| Q3 FY2018 | Sep 30, 2018 | -$10.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$9.16M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.67M | – |
| Q4 FY2017 | Dec 31, 2017 | -$8.70M | – |
| Q3 FY2017 | Sep 30, 2017 | -$7.49M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.18M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.20M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.81M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.77M | – |
See a number that looks wrong?